logo

ARMP

Armata Pharmaceuticals·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ARMP fundamentals

Armata Pharmaceuticals (ARMP) released its earnings on Aug 12, 2025: revenue was 2.17M (YoY 0.00%), beat estimates; EPS was -0.45 (YoY -80.00%), missed estimates.
Revenue / YoY
2.17M
0.00%
EPS / YoY
-0.45
-80.00%
Report date
Aug 12, 2025
EPS
Revenue

Revenue & Expenses

ARMP has released its 2025 Q3 earnings report, with revenue of 1.16M, reflecting a YoY change of -61.02%, and net profit of -26.68M, showing a YoY change of -386.68%. The Sankey diagram below clearly presents ARMP's revenue sources and cost distribution.

Key Indicators

Armata Pharmaceuticals (ARMP) key financial stats and ratios, covering profitability, financial health, and leverage.
Armata Pharmaceuticals (ARMP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Armata Pharmaceuticals (ARMP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Armata Pharmaceuticals (ARMP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Armata Pharmaceuticals (ARMP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Armata Pharmaceuticals (ARMP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield